Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ODS Role As Government Key Advisor Must Be Strengthened – Israelsen

This article was originally published in The Tan Sheet

Executive Summary

The Office of Dietary Supplements should make HHS and FDA "recognize the ODS as [their] key advisor" on supplement issues, Utah Natural Products Alliance Executive Director Loren Israelsen said May 8

You may also be interested in...



NIH’s ODS Strategic Plan Adds Steering Group To Monitor Progress

NIH's Office of Dietary Supplements is instituting a steering group and an annual "external consultative group meeting" in order to review and evaluate its ongoing programs

NIH’s ODS Strategic Plan Adds Steering Group To Monitor Progress

NIH's Office of Dietary Supplements is instituting a steering group and an annual "external consultative group meeting" in order to review and evaluate its ongoing programs

NIH’s ODS Strategic Plan Adds Steering Group To Monitor Progress

NIH's Office of Dietary Supplements is instituting a steering group and an annual "external consultative group meeting" in order to review and evaluate its ongoing programs

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel